Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Elvanse

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract Pharmacological treatment of the attention-deficit/hyperactivity disorder (ADHD) includes use of the psychostimulant… Expand
2018
2018
Amphetamine (AMP) is used as an illicit drug and also for the treatment of attention deficit hyperactivity disorder (ADHD… Expand
Review
2018
Review
2018
Lisdexamfetamine dimesylate (lisdexamfetamine; Elvanse®; Tyvense®), an orally-active dexamfetamine prodrug, is indicated in the… Expand
  • table 1
  • figure 1
Review
2016
Review
2016
Lisdexamfetamine dimesylate (lisdexamfetamine) is a long-acting amfetamine prodrug with a convenient once-daily oral regimen that… Expand
  • table 1
  • table 2
  • figure 1
2015
2015
Lisdexamfetamine is now licensed for use in adults with attention deficit hyperactivity disorder (ADHD) under the brand name… Expand